Inventor · disambiguated record
Robert Zamboni
Also filed as: ZAMBONI ROBERT · ZAMBONI ROBERT J
44 granted patents·14 pending applications·427 citations·filing 1985–2024
98Inventor score
Files withMERCK FROSST CANADA INC23AEROMICS INC8EIDOS THERAPEUTICS INC5ST JUDE CHILDRENS RES HOSPITAL INC4ALUMIS INC2
Top patents by PatentIndex Score
58 records- 0197US11725018B2CrystalsAEROMICS INC·Filed 2021·Granted Aug 15, 2023·4 cites·20 claims
- 0296US4661499A2-[(substituted)-phenoxymethyl]quinolinesMERCK FROSST CANADA INC·Filed 1985·Granted Apr 28, 1987·65 cites·7 claims
- 0395US12091431B2CrystalsAEROMICS INC·Filed 2023·Granted Sep 17, 2024·2 cites·18 claims
- 0494US12213987B2Prodrug saltsAEROMICS INC·Filed 2021·Granted Feb 4, 2025·2 cites·10 claims
- 0594US11117909B2CrystalsAEROMICS INC·Filed 2017·Granted Sep 14, 2021·6 cites·30 claims
- 0694US11071744B2Prodrug saltsAEROMICS INC·Filed 2019·Granted Jul 27, 2021·5 cites·20 claims
- 0793US11078162B2Processes for preparing AG-10, its intermediates, and salts thereofEIDOS THERAPEUTICS INC·Filed 2019·Granted Aug 3, 2021·5 cites·54 claims
- 0892US10258636B2Prodrug saltsAEROMICS INC·Filed 2017·Granted Apr 16, 2019·8 cites·15 claims
- 0992US9827253B2Prodrug saltsAEROMICS INC·Filed 2014·Granted Nov 28, 2017·12 cites·9 claims
- 1090US11919865B2Processes for preparing AG-10, its intermediates, and salts thereofEIDOS THERAPEUTICS INC·Filed 2021·Granted Mar 5, 2024·1 cites·16 claims
- 1190US4851409A2-substituted quinoline dioic acids and pharmaceutical compositionsMERCK FROSST CANADA INC·Filed 1987·Granted Jul 25, 1989·30 cites·9 claims
- 1290US2025313534A1Processes for preparing ag-10, its intermediates, and salts thereofEIDOS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1389US10513497B2Process for preparing AG-10, its intermediates, and salts thereofEIDOS THERAPEUTICS INC·Filed 2018·Granted Dec 24, 2019·6 cites·10 claims
- 1488US2024239751A1Processes for preparing ag-10, its intermediates, and salts thereofEIDOS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1586US8901105B2Prodrug derivatives of (E)-N-methyl-N-((3-M ethylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamideAFFINIUM PHARM INC·Filed 2013·Granted Dec 2, 2014·8 cites·22 claims
- 1685US5270324AFluorinated hydroxyalkylquinoline acids as leukotriene antagonistsMERCK FROSST CANADA INC·Filed 1992·Granted Dec 14, 1993·54 cites·9 claims
- 1785US2025206765A1CrystalsAEROMICS INC·Filed 2024·Application pending·0 cites
- 1883US11547709B2Methods of treating disorders associated with castorST JUDE CHILDRENS RES HOSPITAL INC·Filed 2018·Granted Jan 10, 2023·2 cites·19 claims
- 1982US5232916AQuinoline ether alkanoic acidsMERCK FROSST CANADA INC·Filed 1991·Granted Aug 3, 1993·24 cites·2 claims
- 2081US11891378B2Small molecule modulators of pantothenate kinasesST JUDE CHILDRENS RES HOSPITAL INC·Filed 2018·Granted Feb 6, 2024·2 cites·3 claims
- 2180US11643420B2Benzoxazinone compounds as KLK5/7 dual inhibitorsMOLECULAR SKIN THERAPEUTICS INC·Filed 2020·Granted May 9, 2023·1 cites·14 claims
- 2280US4957932ABenzoheterazolesMERCK FROSST CANADA INC·Filed 1987·Granted Sep 18, 1990·28 cites·13 claims
- 2379US10035813B2Prodrug derivatives of (E)-N-methyl-N-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamideDEBIOPHARM INT SA·Filed 2014·Granted Jul 31, 2018·3 cites·27 claims
- 2479US4962203A2-substituted quinolines useful as leukotriene antagonistsMERCK FROSST CANADA INC·Filed 1989·Granted Oct 9, 1990·14 cites·9 claims
- 2578US7019022B2Substituted tetrahydrocarbazole and cyclopentanoindole derivativesMERCK FROSST CANADA INC·Filed 2004·Granted Mar 28, 2006·11 cites·11 claims
- 2674US6699856B2Pyrazinones, compositions containing such compounds and methods of useMERCK FROSST CANADA INC·Filed 2002·Granted Mar 2, 2004·7 cites·16 claims
- 2774US6225288B1Gamma-ketoacid dipeptides as inhibitors of caspase-3MERK FROSST CANADA & CO·Filed 2000·Granted May 1, 2001·17 cites·14 claims
- 2873US5204358AHetaryl styryl quinolines as leukotriene inhibitorsMERCK FROSST CANADA INC·Filed 1992·Granted Apr 20, 1993·14 cites·8 claims
- 2973US2025090526A1Methods of treating disorders associated with castorST JUDE CHILDRENS RES HOSPITAL INC·Filed 2024·Application pending·0 cites
- 3072US12281123B2Benzoxazinone compounds as KLK5/7 dual inhibitorsMOLECULAR SKIN THERAPEUTICS INC·Filed 2023·Granted Apr 22, 2025·0 cites·6 claims
- 3171US5104882ADiarylstrylquinoline diacids and pharmaceutical compositions thereofMERCK FROSST CANADA INC·Filed 1990·Granted Apr 14, 1992·13 cites·9 claims
- 3270US6444811B1Pyrazinones, compositions containing such compounds and methods of useMERCK FROSST CANADA INC·Filed 2000·Granted Sep 3, 2002·5 cites·1 claims
- 3369US6627656B2Method of treatment using phenyl and biaryl derivatives as prostaglandin E inhibitors and compounds useful thereforeFiled 2001·Granted Sep 30, 2003·5 cites·5 claims
- 3469US5102881AQuinoline ether alkanoic acidsMERCK FROSST CANADA INC·Filed 1989·Granted Apr 7, 1992·8 cites·7 claims
- 3569US2023321092A1Methods of treating disorders associated with castorST JUDE CHILDRENS RES HOSPITAL INC·Filed 2022·Application pending·0 cites
- 3666US8222251B2Pyridopyridazine compounds, compositions and methods of useKAIZERMAN JACOB·Filed 2008·Granted Jul 17, 2012·1 cites·32 claims
- 3764US6066715ALigands for phosphatase binding assayMERCK FROSST CANADA INC·Filed 1997·Granted May 23, 2000·14 cites·4 claims
- 3863US5506227APyridine-substituted benzyl alcohols as leukotriene antagonistsMERCK FROSST CANADA INC·Filed 1992·Granted Apr 9, 1996·18 cites·4 claims
- 3962US2025188093A1Tyk2 inhibitors and uses thereofALUMIS INC·Filed 2023·Application pending·0 cites
- 4062US2025213571A1Tyk2 inhibitors and uses thereofALUMIS INC·Filed 2023·Application pending·0 cites
- 4161US5004743APyridyl styrene dialkanoic acids as anti-leukotriene agentsMERCK FROSST CANADA INC·Filed 1987·Granted Apr 2, 1991·10 cites·10 claims
- 4258US6348572B1Ligands for phosphatase binding assayMERCK FROSST CANADA INC·Filed 1998·Granted Feb 19, 2002·12 cites·5 claims
- 4353US2025339396A1Novel modulators of the melatonin receptors as well as method of manufacture and uses thereofCOSMAS THERAPEUTICS DEV INC·Filed 2022·Application pending·0 cites
- 4452US11401246B2Triazole glycolate oxidase inhibitorsCANTERO THERAPEUTICS INC·Filed 2019·Granted Aug 2, 2022·0 cites·23 claims
- 4552US2023143491A1Triazole glycolate oxidase inhibitorsCANTERO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4652US2025101002A1Deuterated infigratinib compoundsQED THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4747US5037840ABenzothiazolesMERCK FROSST CANADA INC·Filed 1990·Granted Aug 6, 1991·3 cites·12 claims
- 4847US4857659AStereoselective synthesis of leukotriene antagonistsMERCK FROSST CANADA INC·Filed 1987·Granted Aug 15, 1989·2 cites·3 claims
- 4941US10787443B2RAF-degrading conjugate compoundsZAMBONI CHEM SOLUTIONS INC·Filed 2018·Granted Sep 29, 2020·0 cites·27 claims
- 5041US2006058363A1Nitric oxide releasing selective cyclooxygenase-2 inhibitorsWANG ZHAOYIN·Filed 2003·Application pending·0 cites
Showing the top 50 of 58 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →